Heparin Sodium Injection, USP, 20,000 USP units per mL, 25 x 1 mL Multi-Dose Vials, Rx Only, For Intravenous or Subcutaneous Use, Mfd. for: Sagent Pharmaceuticals, Schaumburg, IL 60195; Made in India, NDC carton: 25021-404-01
Published March 15, 2023 · Recall initiated: February 28, 2023
Summary
FDA records drug Class II recall D-0435-2023, published March 15, 2023 and initiated February 28, 2023. Recalling firm: Sagent Pharmaceuticals Inc; Status: Terminated; Reported quantity: 28,875 vials; Lot: Lot#: WP201, Exp 2/2024. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Labeling: Not elsewhere classified
What to do
Voluntary: Firm initiated · Letter
Get an email if HEPARIN SODIUM has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- HEPARIN SODIUM
- Manufacturer
- Sagent Pharmaceuticals Inc
- Distributor
- USA Nationwide
- Lot
- Lot#: WP201, Exp 2/2024
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAHeparin Sodium Injection, USP, 5,000 USP Units/mL, 1mL Multi dose vial x 25 vials per carton, Distributed by:October 28, 2026
- FDAHeparin Sodium, 25,000USP units per 250 mL, (100 USP units per mL) in 5% Dextrose Injection, 250 mL ExcelMarch 15, 2023
- FDAVerapamil Hydrochloride Extended-Release Tablets, USP, 120 mg, Rx Only, 100 Tablets per Carton (10 x 10),March 15, 2023
- FDAHeparin Sodium 2,000, USP Units, per 1,000 mL (2 USP Units/mL) in 0.9% Sodium Chloride Injection, 1,000 mLJanuary 11, 2023
- FDAHEPARIN SODIUM, 1000 USP Heparin Units/500 mL (2 USP Heparin Units/mL), in 0.9% Sodium Chloride Injection, 500December 31, 2014
- FDAHeparin Sodium Injection, USP 10,000 USP units per 10 mL (1,000 USP units per mL) For IV or SC use, Multi-DoseMarch 12, 2014
Questions about this recall
Was Heparin Sodium Injection, USP, 20,000 USP units per mL, 25 x 1 mL Multi-Dose Vials, Rx Only, For Intravenous or Subcutaneous Use, Mfd. for: Sagent Pharmaceuticals, Schaumburg, IL 60195; Made in India, NDC carton: 25021-404-01 recalled?
Yes. FDA published recall D-0435-2023 on March 15, 2023. Reported hazard: Labeling: Not elsewhere classified
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: HEPARIN SODIUM.